As of August 28, 2026, Zenas BioPharma, Inc. (ZBIO) has a DilutionWatch DilutionScore of 25/100, rated LOW dilution risk. Zenas BioPharma, Inc. has a market capitalization of $1.16B, 65.18M shares outstanding, 140 institutional holders tracked.
This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.
Dilution Forecast
☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for ZBIO.
Market Data
Market Cap$1.16B
Shares Outstanding65.18M
Float39.62M
Cash$643.13M
Debt$78.64M
Short InterestN/A
Institutional Holdings
QoQ: ↑ 38.0% shares (2026Q1 vs prior)
140 institutional holders · 58.11M shares
#1
FMR LLC
9.08M shares
#2
SR One Capital Management, LP
5.04M shares
#3
NEA Management Company, LLC
4.02M shares
Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.
Short Interest
Short Interest11.75M
Days to Cover13.8
% of Float29.7%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL CONVERTIBLE
2024-12-31
Full SEC filing analysis available with free account
→
Recent News
No recent news
Factual ZBIO Dilution Snapshot
Zenas BioPharma, Inc. (ZBIO) has a DilutionScore of 25/100, rated Low dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for ZBIO: xbrl on 2024-12-31.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Track ZBIO Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ZBIO — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
More Research for ZBIO
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.